Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| CEO | Kewalramani Reshma | 110.3K | $52.42M | - |
| VP | Sachdev Amit | 68.5K | $32.56M | - |
| COO | Arbuckle Stuart A | 63.4K | $30.13M | - |
| CFO | WAGNER CHARLES F JR | 51.7K | $24.57M | - |
| VP | | 47.3K | $22.47M | -9,532 |
Transactions
50 transactions · page 22
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2020-02-18 | Arbuckle Stuart A | EVP, Chief Commercial Officer | Sell | 980 | $244.52 | $239,627.20 | -1.1% | → |
| 2020-02-11 | Silva Paul M | SVP & Controller | Sell | 5,862 | $246.04 | $1,442,300.86 | -5.0% | → |
| 2020-02-11 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 13,070 | $246.08 | $3,216,310.52 | -4.1% | → |
| 2020-02-11 | Parini Michael | EVP, CL&AO | Sell | 16,882 | $246.11 | $4,154,831.84 | -5.9% | → |
| 2020-02-11 | LEIDEN JEFFREY M | CEO & President | Sell | 47,523 | $246.09 | $11,694,933.45 | -4.9% | → |
| 2020-02-11 | Arbuckle Stuart A | EVP, Chief Commercial Officer | Sell | 11,286 | $246.09 | $2,777,324.66 | -3.5% | → |
| 2020-02-11 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 17,032 | $246.11 | $4,191,771.36 | -5.7% | → |
| 2020-02-10 | Lee Yuchun | Director | Sale+OE | 1,181 | $242.51 | $286,403.43 | -9.2% | → |
| 2020-02-07 | Lee Yuchun | Director | Sale+OE | 2,000 | $237.82 | $475,643.00 | -12.5% | → |
| 2020-02-06 | Lee Yuchun | Director | Sale+OE | 929 | $240.43 | $223,358.85 | -12.9% | → |